ArticleFrontiers in oncology2025
Case Report: Giant mesenteric hemolymphangioma enveloping the ileum.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Rare Presentation of Small Bowel Hemolymphangioma.ACG case reports journal · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemolymphangiomas are rare, benign tumors arising from lymphatic and vascular tissues, most commonly found in subcutaneous and soft tissues, with their occurrence in the gastrointestinal tract, especially the mesentery, being uncommon. Due to their heterogeneous imaging features, these tumors are often misdiagnosed as malignancies, particularly when located in the abdominal cavity. We report a case of a 16-year-old male presenting with abdominal pain, vomiting, and diarrhea for 7 days. Imaging revealed a large, heterogeneous mass in the right lower abdomen, initially suspected to be a malignant mesenteric tumor. An ultrasound-guided biopsy and immunohistochemistry confirmed the diagnosis of hemolymphangioma. The patient underwent a combined laparoscopic and open surgical approach, including en bloc resection of the tumor, along with a segment of the ileum and surrounding mesentery. Histopathological examination verified the presence of lymphatic and vascular components consistent with hemolymphangioma. The patient recovered uneventfully and showed no recurrence at a 3-month follow-up. Hemolymphangiomas, although rare, should be considered in the differential diagnosis of mesenteric tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.